liminal biosciences - Robuta Search

https://www.prnewswire.com/news-releases/liminal-biosciences-announces-closing-of-sale-of-priority-review-voucher-301387187.html Liminal BioSciences Announces Closing of Sale of Priority Review Voucher /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), announced today that its subsidiary Prometic Biotherapeutics... liminal biosciences priority review announces closing sale https://www.biospace.com/liminal-biosciences-shareholders-approve-plan-of-arrangement-with-structured-alpha-lp Liminal Biosciences Shareholders Approve Plan of Arrangement With Structured Alpha LP - BioSpace Sep 18, 2023 - Liminal BioSciences Inc., is pleased to announce that its shareholders have approved the previously-announced plan of arrangement under section 192 of the... liminal biosciences https://www.newswire.ca/news-releases/liminal-biosciences-announces-scientific-presentations-at-upcoming-keystone-symposia-881223237.html Liminal BioSciences Announces Scientific Presentations at Upcoming Keystone Symposia /CNW Telbec/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company" ), a clinical-stage biopharmaceutical company... liminal biosciences scientific presentations announces upcoming keystone https://www.prnewswire.com/news-releases/liminal-biosciences-to-present-at-the-stifel-virtual-healthcare-conference-301172751.html Liminal Biosciences to Present at The Stifel Virtual Healthcare Conference /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced that... liminal biosciences at the virtual healthcare present stifel https://www.prnewswire.com/news-releases/liminal-biosciences-reports-second-quarter-2021-financial-results-301356140.html Liminal BioSciences Reports Second Quarter 2021 Financial Results /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, today reported... liminal biosciences second quarter reports 2021 financial https://www.newswire.ca/news-releases/liminal-biosciences-announces-arrangement-agreement-with-structured-alpha-lp-810030131.html Liminal BioSciences Announces Arrangement Agreement with Structured Alpha LP /CNW/ - Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") (NASDAQ: LMNL) and Structured Alpha LP ("SALP"), a fund managed by Thomvest Asset... liminal biosciences announces arrangement agreement structured https://www.biospace.com/liminal-biosciences-to-reschedule-reporting-of-q3-2020-results-and-conference-call Liminal Biosciences to Reschedule Reporting of Q3 2020 Results and Conference Call - BioSpace Nov 11, 2020 - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, today announced that it will now... https://www.benzinga.com/general/biotech/22/01/25128078/liminal-biosciences-pauses-development-of-fezagepras-outlines-r-d-priorities-for-2022 Liminal BioSciences Pauses Development Of Fezagepras, Outlines R&D Priorities For 2022 - Benzinga Jan 20, 2022 - Following the analysis of the preliminary pharmacokinetic data from the Phase I MAD trial, Liminal BioSciences Inc (NASDAQ: LMNL) said that it